HealthEquity, Inc.
NASDAQ:HQYMedical - Healthcare Information Services
-$0.54 today
- Market cap
- $8.05B
- Beta
- 0.21
- P/E (TTM)
- 31.4
- EPS (TTM)
- $2.73
Volume 1.29M
Average 0.98M
HQY Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
HealthEquity, Inc.NASDAQ: HQY
Stock-Based Compensation · Q2 FY2027 · quarter ended Jul 2026
Stock-based compensation growth accelerates
Q2 FY2027 stock-based compensation of $22.21M rose 16.5% year over year, ahead of the +6.6% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 14.4% from the prior quarter. Over 3 fiscal years it compounded at +5.3% a year.
Context
- Stock-based compensation amounted to 5.6% of revenue in FY2026, down 2.5 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +16.5% holds above the trailing-twelve-month pace of +6.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2026
- 73.06M USD
- Year-over-year change
- -24.2%
- 4-year CAGR
- +8.5%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 73.06M | -24.2% |
| FY2025 | 2025-01-31 | 96.43M | +25.0% |
| FY2024 | 2024-01-31 | 77.15M | +23.2% |
| FY2023 | 2023-01-31 | 62.61M | +18.7% |
| FY2022 | 2022-01-31 | 52.75M | — |
Stock-Based Compensation vs competitors
How HQY compares with its peers on the latest reported figures
- HQY's LTM Jul 2026 stock-based compensation of $81.28M is the largest of the 8 companies compared; the peer median is $28.39M.
- Its year-over-year change of +6.6% is the 3rd highest of 8, against a peer median of -5.3%.
- Stock-based compensation amounts to 6.0% of revenue for HQY, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $81.28M | +6.6% | +5.3% | 6.0% | |
| LTM Apr 2026 | $63.78M | -5.3% | +4.7% | 12.9% | |
| LTM Jun 2026 | $49.04M | +47.7% | +73.9% | 4.1% | |
| LTM Mar 2026 | $31.24M | -24.7% | -13.3% | 2.5% | |
CTEVClaritev Corporation | LTM Mar 2026 | $28.39M | +2.6% | +18.5% | 2.9% |
| LTM Mar 2026 | $16.98M | -56.1% | -31.2% | 7.2% | |
| LTM Mar 2026 | $14.32M | +52.4% | +24.9% | 5.1% | |
| LTM Mar 2026 | $67K | -92.8% | -54.8% | 0.1% | |
| Peer median (excluding HQY) | $28.39M | -5.3% | +4.7% | 4.1% | |
Competitors are the stored peer set for HQY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (44.29M) | (26.14M) | 55.71M | 96.7M | 215.2M |
| Depreciation & Amortization | 137.19M | 161.2M | 153.08M | 162.45M | 154.66M |
| Deferred Income Tax | (23.43M) | (17.18M) | (14M) | (12.84M) | 39.73M |
| Stock-Based Compensation | 52.75M | 62.61M | 77.15M | 96.43M | 73.06M |
| Change in Working Capital | 1.63M | (33.37M) | (33.13M) | (6.53M) | (26.62M) |
| Accounts Receivables | (11.2M) | (9.57M) | (8.06M) | (13.11M) | (5.69M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (2.18M) | (26.67M) | (204K) | 8.89M | 1.71M |
| Other Working Capital | 15.01M | 2.87M | (24.87M) | (2.31M) | (22.64M) |
| Other Non-Cash Items | 17.15M | 3.53M | 4.01M | 3.64M | 1.06M |
| Operating Cash Flow | 141M | 150.65M | 242.83M | 339.86M | 457.09M |
| Capital Expenditures | (137.08M) | (119.13M) | (46.07M) | (2.08M) | (1.97M) |
| Acquisitions (Net) | (504.53M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 128.17M | 0 | 0 | 0 | 0 |
| Sales of Investments | 2.37M | 0 | 0 | 0 | 0 |
| Other Investing Activities | (128.17M) | 0 | (44.38M) | (503.37M) | (45.17M) |
| Investing Cash Flow | (639.25M) | (119.13M) | (46.07M) | (505.45M) | (47.14M) |
| Debt Repayment | (65.05M) | (8.75M) | (54.38M) | 171.25M | (100M) |
| Common Stock Issued | 466.39M | 6.68M | 6.47M | 9.43M | 11.41M |
| Common Stock Repurchased | 0 | 0 | 0 | (121.49M) | (299.25M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (6.49M) | (603K) | 865K | (1.62M) | 867K |
| Financing Cash Flow | 394.86M | (2.67M) | (47.04M) | 57.57M | (386.98M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (103.39M) | 28.85M | 149.71M | (108.03M) | 22.98M |
| Free Cash Flow | 3.91M | 31.52M | 196.75M | 337.77M | 455.13M |
HealthEquity, Inc.
NASDAQ:HQY
Intrinsic Alpha fair value
Locked
Current Price
$97.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.